Dr. Behzad Amoozgar's key publications in hematology and oncology, emphasizing his significance and contributions to advancing patient care and research:

​

1. Survival Outcomes of US Patients with CMML: A Two-Decade Analysis from the SEER Database
Year: 2024
This study utilized the SEER database to evaluate survival trends and factors influencing outcomes in patients with chronic myelomonocytic leukemia (CMML). The findings provide a comprehensive understanding of CMML survival dynamics, offering insights into disease management and long-term prognosis.

​

2. Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM)
Year: 2024
Published in Journal of Clinical Medicine, this work assessed the integration of allo-SCT with CAR-T therapy in relapsed/refractory multiple myeloma. It highlights the challenges and benefits of combining these advanced therapeutic modalities in heavily pretreated patients.

​

3. Tafasitamab and Lenalidomide in Large B-Cell Lymphoma: Real-World Outcomes in a Multicenter Retrospective Study
Year: 2023
This multicenter retrospective analysis, published in Blood, evaluated the efficacy and safety of tafasitamab and lenalidomide in large B-cell lymphoma. It provides real-world evidence supporting the clinical application of this combination therapy for relapsed/refractory cases.

​

4. Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B-Cell Lymphoma
Year: 2023
This study explored the outcomes of sequential CD19-directed therapies in relapsed/refractory large B-cell lymphoma, offering a framework for optimizing sequencing strategies to improve patient outcomes.

​

5. Loncastuximab in High-Risk and Heavily Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Analysis from 21 US Centers
Year: 2023
A comprehensive analysis of loncastuximab’s efficacy and safety in high-risk diffuse large B-cell lymphoma, this publication provides real-world data supporting its use in heavily pretreated patient populations.

​

6. Initial Treatment of Elderly Populations with Aggressive Lymphoma: A Narrative Review of Current Evidence and Future Directions
Year: 2022
Published in Annals of Lymphoma, this review highlights tailored therapeutic strategies for elderly patients with aggressive lymphomas, focusing on balancing treatment efficacy with tolerability.

​

7. Presentation of Diffuse Large B-Cell Lymphoma with Shoulder Pain: A Case Report
Year: 2021
This case report highlights an atypical presentation of diffuse large B-cell lymphoma, underscoring the importance of considering lymphoma in differential diagnoses of unusual pain syndromes.

​

8. The Clinical Challenges of Diagnosing Acutely Decompensating Amyloidosis
Year: 2020
This publication explores diagnostic challenges in amyloidosis, a condition often overlapping with hematologic malignancies, emphasizing early detection to improve outcomes.